Zydus Lifesciences arm Zydus Noveltech dissolves
Ahmedabad: Zydus Lifesciences has announced that Zydus Noveltech Inc., USA, (ZNI) a wholly owned subsidiary of the Company, incorporated in New Jersey, has been dissolved w.e.f. December 15, 2023 pursuant to certificate of dissolution dated December 17, 2023.
ZNI had nil operating revenue and a net worth of Rs 10 crore as of March 31, 2023.
As per the Company, ZNI has voluntarily closed its business operations in view of the fact that it had only one product commercialized in the US market through its associate, which was not generating any meaningful revenue and margins due to its limited scale.
Also, ZNI has been incurring losses as the Company could not launch any other products in the US market and utilize the services of ZNI, which could have made operations commercially viable.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.